UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 3 | March 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 2 Issue 5
May-2015
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1701805


Registration ID:
405781

Page Number

760-772

Share This Article


Jetir RMS

Title

Cisplatin : “The Impact in Cancer Therapy”

Abstract

Cisplatin is called the "penicillin of cancer" because it is used so widely and it was the first big chaemotherapy drug, It is most widely prescribed as well as a first and effective treatment for many cancer diagnoses. Unlike many cancer drugs, which are organic molecules with complex structures, cisplatin is an inorganic molecule with a simple structure. In designing and evaluating new cancer treatments, researchers use cisplatin as the gold standard against which new medicines are compared. This drug is probably most widely known for its prominent role in in fighting multiple cancer types. Cisplatin is used to treat many types of cancer, but it is most widely prescribed for testicular, ovarian, bladder, lung, and stomach cancers. Cisplatin, is a well-known chemotherapeutic drug. It has been used for treatment of numerous human cancers including bladder, head and neck, lung, ovarian, and testicular cancers. It is effective against various types of cancers, including carcinomas, germ cell tumors, lymphomas, and sarcomas. Its mode of action has been linked to its ability to crosslink with the purine bases on the DNA; interfering with DNA repair mechanisms, causing DNA damage, and subsequently inducing apoptosis in cancer cells. However, because of drug resistance and numerous undesirable side effects such as severe kidney problems, allergic reactions, decrease immunity to infections, gastrointestinal disorders, hemorrhage, and hearing loss especially in younger patients, other platinum-containing anti-cancer drugs such as carboplatin, oxaliplatin and others, have also been used. Cisplatin is called the "penicillin of cancer" because it is used so widely and it was the first big chaemotherapy drug, It is most widely prescribed as well as a first and effective treatment for many cancer diagnoses. Unlike many cancer drugs, which are organic molecules with complex structures, cisplatin is an inorganic molecule with a simple structure. In designing and evaluating new cancer treatments, researchers use cisplatin as the gold standard against which new medicines are compared. This drug is probably most widely known for its prominent role in in fighting multiple cancer types. Cisplatin is used to treat many types of cancer, but it is most widely prescribed for testicular, ovarian, bladder, lung, and stomach cancers. Cisplatin, is a well-known chemotherapeutic drug. It has been used for treatment of numerous human cancers including bladder, head and neck, lung, ovarian, and testicular cancers. It is effective against various types of cancers, including carcinomas, germ cell tumors, lymphomas, and sarcomas. Its mode of action has been linked to its ability to crosslink with the purine bases on the DNA; interfering with DNA repair mechanisms, causing DNA damage, and subsequently inducing apoptosis in cancer cells. However, because of drug resistance and numerous undesirable side effects such as severe kidney problems, allergic reactions, decrease immunity to infections, gastrointestinal disorders, hemorrhage, and hearing loss especially in younger patients, other platinum-containing anti-cancer drugs such as carboplatin, oxaliplatin and others, have also been used. Furthermore, combination therapies of cisplatin with other drugs are to be highly considered to overcome drug-resistance and reduce toxicity. This comprehensive review highlights the physicochemical properties of cisplatin and related platinum-based drugs, and discusses its uses either alone or in combination with other drugs for the treatment of various human cancers. A special attention is to be given to its molecular mechanisms of action, and its undesirable side effects.

Key Words

Cisplatin, Platinum-based drugs, Mechanisms of action, cisplatin combination therapy, Cancer treatment, Cisplatin Pharmacology and Toxicological effects of Cisplatin.

Cite This Article

"Cisplatin : “The Impact in Cancer Therapy”", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.2, Issue 5, page no.760-772, May 2015, Available :http://www.jetir.org/papers/JETIR1701805.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Cisplatin : “The Impact in Cancer Therapy”", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.2, Issue 5, page no. pp760-772, May 2015, Available at : http://www.jetir.org/papers/JETIR1701805.pdf

Publication Details

Published Paper ID: JETIR1701805
Registration ID: 405781
Published In: Volume 2 | Issue 5 | Year May-2015
DOI (Digital Object Identifier):
Page No: 760-772
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000230

Print This Page

Current Call For Paper

Jetir RMS